Ironwood is advancing apraglutide, a next-generation, synthetic glucagon-like peptide-2 (“GLP-2”) analog for short bowel syndrome (“SBS”) patients dependent on parenteral support (“PS”), a severe ...

EL CENTRO — The proposed $256 million Ironwood Transmission Line would span a portion of Yuma County, Arizona, and southern Imperial County, California, transmitting what has been described as ...

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday ...